Basilea Pharmaceutica AG (SWX:BSLN)

Basilea Pharmaceutica AG Revenue

Basilea Pharmaceutica AG had revenue of 103.96M CHF in the half year ending June 30, 2025, with 22.44% growth. This brings the company's revenue in the last twelve months to 236.21M, up 58.51% year-over-year. In the year 2024, Basilea Pharmaceutica AG had annual revenue of 208.54M with 32.30% growth.

• Revenue (ttm): 236.21M
• Revenue Growth: +58.51%
• P/S Ratio: 2.81
• Revenue / Employee: 1.31M
• Employees: 180
• Market Cap: 663.56M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	208.54M	50.91M	32.30%
Dec 31, 2023	157.63M	9.87M	6.68%
Dec 31, 2022	147.77M	-357.00K	-0.24%
Dec 31, 2021	148.12M	20.49M	16.06%
Dec 31, 2020	127.63M	-6.75M	-5.02%